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Letters to the Editor
Response to “Best (but oft forgotten) practices:
testing for treatment effects in randomized trials by
separate analyses of changes from baseline in each
group is a misleading approach”
Dear Editor:
We were surprised to see our study (1) used as the first example of
how not to compare group means with each other in the recent article by
Bland and Altman (2), because, in fact, our conclusions were not based
on within-group comparisons. However, because of size limits of the
abstract, we presented the within-group comparisons to provide as clear
a picture as possible regarding the effects of glucose, fructose, and high-
fructose corn syrup (HFCS) consumption on lipid/lipoprotein risk factors
for cardiovascular disease. In retrospect we should have attempted to
make the following statistically more appropriate (but 37 words
longer) summary of our results fit into the abstract, as follows:
Results: The effects of consuming HFCS on the main
outcomes were comparable to those of fructose and signifi-
cantly higher than those of glucose. Changes (Δ) in 24-h
triglyceride area under the curve (P ¼ 0.0058, effect of
sugar)—HFCS:11.86 1.4 mmol/L3 24 h; fructose:14.76
1.2 mmol/L 3 24 h (P ¼ 0.74 compared with HFCS,
Tukey’s); glucose: 21.9 6 0.9 mmol/L 3 24 h (P ¼ 0.034
compared with HFCS). Fasting LDL (P ¼ 0.0098, effect of
sugar)—HFCS: 10.42 6 0.11 mmol/L; fructose: 10.29 6
0.082 mmol/L (P ¼ 0.67 compared with HFCS);
glucose: 10.012 6 0.071 mmol/L (P ¼ 0.0083 compared
with HFCS). Fasting apolipoprotein B (P ¼ 0.0051, effect of
sugar)—HFCS:10.126 0.031 g/L; fructose:10.0936 0.022
g/L (P ¼ 0.87 compared with HFCS); glucose: 10.0097 6
0.019 g/L (P ¼ 0.0056 compared with HFCS).
Our reporting of the within-group, rather than between-group,
comparisons in the abstract certainly could not mislead the reader.
Both the between- and within-group comparisons reported in Tables
2 and 3 of the article support our conclusion that “Consumption of
HFCS-sweetened beverages for 2 weeks at 25%E increased risk
factors for cardiovascular disease comparably to fructose and more
than glucose in young adults.”
It should also be noted that in the 4 y since this article was published,
standards for the reporting of statistics and clinical trial results have
changed considerably, and the policies ofmost high-impact journals have
changed accordingly. For example, in 2009, a reviewer of our article pub-
lished in the Journal of Clinical Investigation (3) critiqued our between-
group statistical model as difficult to understand. Thus, we were in-
structed by the editor to move our tables describing the between-group
differences to the supplement and, in the main article, replace them with
tables that showed only the within-group changes with P values. Again,
the intent was to clarify, not to mislead.
Neither of the authors had a conflict of interest.
Kimber L Stanhope
Peter J Havel
From the Department of Molecular Biosciences, School of
Veterinary Medicine, and the Department of Nutrition,
University of California, Davis, Davis, CA (PJH; KLS,
e-mail: klstanhope@ucdavis.edu).
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Reply to KL Stanhope and PJ Havel
Dear Editor:
We thank Stanhope and Havel for their interest. We used their ar-
ticle as our first example because they gave both the comparison be-
tween groups, which we regard as correct and said so, and the separate
comparisons against baseline, which we were criticizing. We could
therefore compare the two.
Wewere interested to learn of their experiences of journals that insist
that they carry out or emphasize potentially misleading analyses. We
have had similar experiences and sympathize. We did not intend to sug-
gest that the authors of the examples we cited were deliberately trying to
mislead readers, but that separate comparisons against baseline are mis-
leading and, we argue, seldom of any value.
Neither of the authors had a conflict of interest.
J Martin Bland
Douglas G Altman
From the Department of Health Sciences, University of York,
York, United Kingdom (JMB, e-mail: martin.bland@york.ac.uk),
and the Centre for Statistics in Medicine, Nuffield
Department of Orthopedics, Rheumatology, and
Musculoskeletal Sciences, University of Oxford, Oxford,
United Kingdom (DGA).
doi: 10.3945/ajcn.115.125997.
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